3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Whooping Cough
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumococcal Infections
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Measles
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Hepatitis B
1
HIV Infections
1
Interventions
fludarabine
5
Cyclophosphamide
5
Cyclosporine
4
fludarabine phosphate
3
Whole-Body Irradiation
3
Imatinib Mesylate
3
Therapeutics
2
Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Methotrexate
2
Hematologic Tests
2
Busulfan
2
Antilymphocyte Serum
2
thymoglobulin
1
nilotinib
1
bosutinib
1
Urinalysis
1
Transplantation, Homologous
1
Tetanus Toxoid
1
Standard of Care
1
Resistance Training
1
Registries
1
Radiotherapy
1
Pharmaceutical Services
1
Ondansetron
1
Nurse Clinicians
1
Modafinil
1
Melphalan
1
Health Promotion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Tetanus Toxoid
×
Clear all
NCT01611298
2020-04-21
TAR
Baylor College of Medicine
Phase NA
Completed
7 enrolled
8 charts